368 related articles for article (PubMed ID: 1681036)
1. Dopaminergic receptors linked to adenylate cyclase in human cerebromicrovascular endothelium.
Bacic F; Uematsu S; McCarron RM; Spatz M
J Neurochem; 1991 Nov; 57(5):1774-80. PubMed ID: 1681036
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
3. Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium.
Bacic F; McCarron RM; Uematsu S; Spatz M
Metab Brain Dis; 1992 Sep; 7(3):125-37. PubMed ID: 1331735
[TBL] [Abstract][Full Text] [Related]
4. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors.
Lovenberg TW; Nichols DE; Nestler EJ; Roth RH; Mailman RB
Brain Res; 1991 Aug; 556(1):101-7. PubMed ID: 1682005
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
Olianas MC; Onali P
J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
[TBL] [Abstract][Full Text] [Related]
6. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
[TBL] [Abstract][Full Text] [Related]
7. Epinephrine and norepinephrine stimulation of adenylate cyclase in bovine retina homogenate: evidence for interaction with the dopamine D1 receptor.
Vanderheyden P; Ebinger G; Kanarek L; Vauquelin G
Life Sci; 1986 Mar; 38(13):1221-7. PubMed ID: 3007905
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells.
Johnston CA; Cumbay MG; Vortherms TA; Watts VJ
FEBS Lett; 2001 May; 497(2-3):85-9. PubMed ID: 11377418
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
Barton AC; Black LE; Sibley DR
Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
[TBL] [Abstract][Full Text] [Related]
11. A primordial dopamine D1-like adenylyl cyclase-linked receptor from Drosophila melanogaster displaying poor affinity for benzazepines.
Sugamori KS; Demchyshyn LL; McConkey F; Forte MA; Niznik HB
FEBS Lett; 1995 Apr; 362(2):131-8. PubMed ID: 7720859
[TBL] [Abstract][Full Text] [Related]
12. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
Gordon EA; Kohout TA; Fishman PH
J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
14. Exfoliation of the beta-adrenergic receptor and the regulatory components of adenylate cyclase by cultured rat glioma C6 cells.
Kassis S; Lauter CJ; Stojanov M; Salem N
Biochim Biophys Acta; 1986 May; 886(3):474-82. PubMed ID: 2871868
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence that lithium inactivates Gi modulation of adenylate cyclase in brain.
Masana MI; Bitran JA; Hsiao JK; Potter WZ
J Neurochem; 1992 Jul; 59(1):200-5. PubMed ID: 1319465
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.
Kelly E; Willcocks AL; Nahorski SR
Naunyn Schmiedebergs Arch Pharmacol; 1987 Jun; 335(6):618-23. PubMed ID: 2819742
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of the epidermal adenylate cyclase system: agonists and phorbol esters desensitize by independent mechanisms.
Iizuka H; Asano K; Ito F; Tamura T; Takahashi H; Tsutsui M
Biochim Biophys Acta; 1991 Jun; 1093(1):95-101. PubMed ID: 1646651
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus.
Grilli M; Nisoli E; Memo M; Missale C; Spano PF
Neurosci Lett; 1988 May; 87(3):253-8. PubMed ID: 2898118
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor subtypes are coupled to adenylate cyclase via different guanyl nucleotide-binding proteins in vasculature.
Eguchi S; Hirata Y; Imai T; Marumo F
Endocrinology; 1993 Feb; 132(2):524-9. PubMed ID: 7678793
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.
Nisoli E; Grilli M; Memo M; Missale C; Spano PF
Neurosci Lett; 1988 May; 87(3):247-52. PubMed ID: 2898117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
